AI assistant
Sending…
Instil Bio, Inc. — Director's Dealing 2025
Apr 28, 2025
33728_dirs_2025-04-28_11a47fcb-f0ef-4aa4-931f-43704167c576.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2025-04-25
Reporting Person: Laumas Sandeep (CFO and CBO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-25 | Employee Stock Option (right to buy) | $12.78 | A | 44851 | Acquired | 2035-04-24 | Common Stock (44851) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
More from Instil Bio, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Jan 6
Interim / Quarterly Report
2025
Nov 13